Nombre del producto:2-(trans-4-Hydroxycyclohexyl)isoindoline-1,3-dione

IUPAC Name:2-[(1r,4r)-4-hydroxycyclohexyl]-2,3-dihydro-1H-isoindole-1,3-dione

CAS:99337-98-1
Fórmula molecular:C14H15NO3
Pureza:95%+
Número de catálogo:CM148256
Peso molecular:245.28

Unidad de embalaje Stock disponible Precio($) Cantidad
CM148256-1g in stock ǫŪƿ
CM148256-5g in stock ȯƛŪ
CM148256-10g in stock ƥŞȐ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :99337-98-1
Fórmula molecular:C14H15NO3
Punto de fusión:-
Código de sonrisas:O=C1N([C@H]2CC[C@H](O)CC2)C(C3=C1C=CC=C3)=O
Densidad:
Número de catálogo:CM148256
Peso molecular:245.28
Punto de ebullición:410°C at 760 mmHg
Nº Mdl:
Almacenamiento:Store at 2-8°C.

Category Infos

Cyclohexanes
Cyclohexane is an organic compound with a chemical formula C6H12. It is a colorless liquid with a pungent odor, insoluble in water, and soluble in most organic solvents such as ethanol, ether, benzene, and acetone. Cyclohexyl fragments are a common structure in both natural and synthetic drugs. It can be used as both core structure and part of achiral side chain.

Column Infos

Cadisegliatin
vTv Therapeutics announces FDA submission for first phase 3 study of Cadisegliatin in patients with type 1 diabetes. Cadisegliatin (TTP399) is developed as an adjunctive therapy to insulin for the treatment of type 1 diabetes, and the phase 3 trial evaluates its safety and efficacy.
Glucokinase (GK) is mainly concentrated in liver cells, and involved in the regulation of glucose metabolism. Cadisegliatin (TTP399) is a liver-selective glucosekinase activator with a mechanism of action different from that of antidiabetic drugs. It binds to the allosteric site of GK and restores innate glucose-regulating capacity of the liver, not disrupting the interaction between GK and GKRP. Cadisegliatin previously received a Breakthrough Therapy designation from the U.S. FDA.

Related Products